Patients With Budd–Chiari Syndrome Have Variable Coagulation Status on Thromboelastography at Diagnosis

Janssen, 1998, Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis, Eur J Gastroenterol Hepatol, 10, A69, 10.1097/00042737-199812000-00222 Mahmoud, 1997, Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis, Gut, 40, 798, 10.1136/gut.40.6.798 Plessier, 2008, Budd-chiari syndrome, Semin Liver Dis, 28, 259, 10.1055/s-0028-1085094 Mohanty, 2001, Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India, Hepatology, 34, 666, 10.1053/jhep.2001.27948 Shukla, 2010, Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone, Indian J Gastroenterol, 29, 8, 10.1007/s12664-010-8002-1 Denniger, 2000, Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors, Hepatology, 31, 587, 10.1002/hep.510310307 Tripodi, 2017, Changing concepts of cirrhotic coagulopathy, Am J Gastroenterol, 112, 274, 10.1038/ajg.2016.498 LismanT, 2010, Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences, Blood, 116, 878, 10.1182/blood-2010-02-261891 Tripodi, 2005, Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests, Hepatology, 41, 553, 10.1002/hep.20569 Salooja, 2001, Thrombelastography, Blood Coagul Fibrinolysis, 12, 327, 10.1097/00001721-200107000-00001 De Pietri, 2015, Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial, Hepatology, 63, 566, 10.1002/hep.28148 Handa, 1997, Thromboelastography: an effective screening test for prothrombotic states, Phlebology, 12, 159 Oshita, 1999, Quantitative measurement of thromboelastography as a function of platelet count, Anesth Analg, 89, 296, 10.1213/00000539-199908000-00006 Murad, 2004, Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome, Hepatology, 39, 500, 10.1002/hep.20064 Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Stravitz, 2012, Potential applications of thromboelastography in patients with acute and chronic liver disease, Gastroenterol Hepatol, 8, 513 Luddington, 2005, Thrombelastography/thromboelastometry, Clin Lab Haematol, 27, 81, 10.1111/j.1365-2257.2005.00681.x Ganter, 2008, Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices, Anesth Analg, 106, 1366, 10.1213/ane.0b013e318168b367 Steer, 1993, Thromboelastography and Sonoclot analysis in the healthy parturient, J Clin Anesth, 5, 419, 10.1016/0952-8180(93)90108-Q Janssen, 2012, Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis, Blood, 120, 4921, 10.1182/blood-2011-09-376517 O'Donnell, 2004, Role of the Thrombelastograph as an adjunctive test in thrombophilia screening, Blood Coagul Fibrinolysis, 15, 207, 10.1097/00001721-200404000-00002 Miall, 2005, Coagulation status and complications of pregnancy, Thromb Res, 115, 461, 10.1016/j.thromres.2004.09.019 McCrath, 2005, Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction, Anesth Analg, 100, 1576, 10.1213/01.ANE.0000155290.86795.12 Yao, 2014, Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke, Cerebrovasc Dis, 38, 182, 10.1159/000365652 James, 2010, Use of Thromboelastography PlateletMapping to monitor antithrombotic therapy in a patient with Budd-Chiari syndrome, Liver Transplant, 16, 38, 10.1002/lt.21933 Kang, 1985, Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation, Anesth Analg, 64, 888, 10.1213/00000539-198509000-00008 Porte, 1989, Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation, Transplantation, 47, 978, 10.1097/00007890-198906000-00012 Rautou, 2011, Bleeding in patients with budd–chiari syndrome, J Hepatol, 54, 56, 10.1016/j.jhep.2010.06.019 Karasoy, 2014, Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark, Eur Heart J, 36, 307, 10.1093/eurheartj/ehu421 Chau, 1998, Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding, Gut, 43, 267, 10.1136/gut.43.2.267 Jain, 2017, Bleeding complications in patients with budd-chiari syndrome on anticoagulation, J Clin Exp Hepatol, 7, S99, 10.1016/j.jceh.2017.05.178 Papatheodoridis, 1999, Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography, Hepatology, 29, 1085, 10.1002/hep.510290437 Montalto, 2002, Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study, J Hepatol, 37, 463, 10.1016/S0168-8278(02)00208-8 Ben-Ari, 1997, Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography, J Hepatol, 26, 554, 10.1016/S0168-8278(97)80420-5 Dai, 2009, Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature, Anesth Analg, 108, 734, 10.1213/ane.0b013e31818f8907 Scarpelini, 2009, Normal range values for thromboelastography in healthy adult volunteers, Braz J Med Biol Res [Internet], 42, 1210, 10.1590/S0100-879X2009001200015